相关实验视频
Updated: Jul 16, 2025

05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.2K
关于动脉样硬化炎症的最新情况:如何有效治疗残留风险
N Mohammadnia1, T S J Opstal2, S El Messaoudi1
1Department of Cardiology, Radboudumc, Nijmegen, the Netherlands.
Clinical therapeutics
|September 16, 2023
概括
与降低脂质一起向炎症是动脉样硬化心血管疾病 (ASCVD) 治疗的关键. 试验表明,抗炎药物可以改善ASCVD的结果,解决残留风险.
科学领域:
- 心血管医学 心血管医学
- 炎症研究 炎症研究
- 临床试验 临床试验
背景情况:
- 炎症在动脉样硬化心血管疾病 (ASCVD) 中起着重要作用.
- 在ASCVD中,即使在最佳的降脂疗法后,残留风险仍然存在.
- 新兴研究探索ASCVD的新型炎症途径和生物标志物.
研究的目的:
- 审查炎症对ASCVD的贡献.
- 评估最近发表的论文和正在进行的关于动脉样硬化炎症在临床护理中的试验的影响.
主要方法:
- 对当前文献和正在进行的临床试验进行批判性审查.
- 对调查抗炎药物 (例如,卡纳基努马布,素) 的关键试验的分析.
主要成果:
- 像CANTOS,COLCOT和LoDoCo2这样的试验表明,通过抑制炎症,ASCVD的结果得到了改善.
- 胆固醇晶体会激活炎症酶,从而导致ASCVD的发病.
- 高灵敏度C反应蛋白和中性粒细胞与淋巴细胞的比率是残留风险的关键生物标志物.
结论:
- 针对炎症对于未来的ASCVD治疗策略至关重要.
- 目前正在进行的试验将进一步确定抗炎剂在ASCVD管理中的作用.
- 结合炎症标志物的个性化方法可以优化患者的护理.
相关概念视频
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Inflammation
53.8K
Overview
53.8K
Atherosclerosis IV: Nursing Management
21
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13

